[artículo]
| Título : |
A randomized, double blind, parallel-group, fixed dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment resistant schizophrenia or schizoaffective disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
Jean-Pierre Lindenmayer, Autor ; Leslie L. Citrome, Autor ; Anzalee Khan, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 160-168 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Dosis altas de quetiapina, Esquizofrenia resistente al tratamiento |
| Resumen: |
Quetiapine is often prescribed at doses higher than those approved by regulatory authorities, with limited evidence from controlled trials. The objective of this study was to assess the safety, tolerability, and efficacy of high-dose quetiapine (1200 mg/d) compared with a standard dose of 600 mg/d among patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, schizophrenia or schizoaffective disorder hospitalized at 2 state-operated psychiatric facilities. |
| Link: |
./index.php?lvl=notice_display&id=29384 |
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 160-168
[artículo] A randomized, double blind, parallel-group, fixed dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment resistant schizophrenia or schizoaffective disorder [texto impreso] / Jean-Pierre Lindenmayer, Autor ; Leslie L. Citrome, Autor ; Anzalee Khan, Autor . - 2022 . - pp. 160-168. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 160-168
| Palabras clave: |
Dosis altas de quetiapina, Esquizofrenia resistente al tratamiento |
| Resumen: |
Quetiapine is often prescribed at doses higher than those approved by regulatory authorities, with limited evidence from controlled trials. The objective of this study was to assess the safety, tolerability, and efficacy of high-dose quetiapine (1200 mg/d) compared with a standard dose of 600 mg/d among patients with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, schizophrenia or schizoaffective disorder hospitalized at 2 state-operated psychiatric facilities. |
| Link: |
./index.php?lvl=notice_display&id=29384 |
|
Refinar búsquedaA randomized, double blind, parallel-group, fixed dose, clinical trial of quetiapine at 600 versus 1200 mg/d for patients with treatment resistant schizophrenia or schizoaffective disorder en Journal of Clinical Psychopharmacology, Año 2011 - Vol. 31 - No. 2 (Abril)
